approvalsd said the for their drug were quite soon, i think with some of these other therapies and also for the vaccine, you need to have data for this. these thingselease under emergency use authorizations and we have seen some of that for example on the convalescent plasma being used, the hydroxychloroquine being used that was issued and pulled back. we certainly will be seeing more approvals go out, but i think some of that will require the collection of a lot more data. have enough data on this regeneron experiment drug to know that it is to be approved? >> i do not have the answer to that on the top of my head, i think the trial they have released with data on just a couple days ago is in early trial. they have described it as a phase hi -- phase one, 2, 3 trial. beis probably going to months before we do have something like that. these are things that do not move at the speed of days or takes a careful amount of time reviewing these things, you do not want to get it wrong especially in the middle of a pandemic where it is liable to be used in lots and lots of people. joe: what is